FibroBiologics, Inc. Common Stock
General ticker "FBLG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $35.2M (TTM average)
FibroBiologics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -41.4%.
Estimated limits based on current volatility of 43.0%: low 0.67$, high 1.68$
Factors to consider:
- Total employees count: 13 as of 2024
- Current price 89.0% below estimated low
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [17.91$, 60.12$]
- 2025-12-31 to 2026-12-31 estimated range: [12.87$, 41.82$]
Short-term FBLG quotes
Long-term FBLG plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $13.74MM |
| Operating Income | $-13.74MM |
| Non-Operating Income | $2.58MM |
| Interest Expense | $0.02MM |
| R&D Expense | $4.50MM |
| Income(Loss) | $-11.16MM |
| Profit(Loss)* | $-11.16MM |
| Stockholders Equity | $2.73MM |
| Assets | $16.45MM |
| Operating Cash Flow | $-11.90MM |
| Capital expenditure | $0.18MM |
| Investing Cash Flow | $-0.18MM |
| Financing Cash Flow | $16.91MM |
| Earnings Per Share** | $-6.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.